Follicular Lymphoma; Scientists at University of Pavia discuss research in follicular lymphoma
Follicular Lymphoma; Scientists at University of Pavia discuss research in follicular lymphoma
About this item
Full title
Follicular Lymphoma; Scientists at University of Pavia discuss research in follicular lymphoma
Publisher
Atlanta: NewsRx
Journal title
Hematology Week, 2008, p.172
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Primary end point was progression-free survival (PFS). Secondary end points were the in vivo purging effect on stem-cell harvest and the impact of molecular response on the outcome. At enrollment, 59% of patients were PCR+ for bcl-2 rearrangement in bone marrow (PCR-informative). After the immunochemotherapy, before mobilization, 97% obtained compl...
Alternative Titles
Full title
Follicular Lymphoma; Scientists at University of Pavia discuss research in follicular lymphoma
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_194652259
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_194652259
Other Identifiers
ISSN
1543-6721
E-ISSN
1543-673X
How to access this item
Log in as a Library member
